Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03016338
Title Study of Niraparib in Recurrent Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

endometrial cancer

Therapies

Niraparib

Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.